A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 54,882 shares of PACB stock, worth $108,117. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,882
Previous 56,072 2.12%
Holding current value
$108,117
Previous $76,000 22.37%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.2 - $2.17 $1,428 - $2,582
-1,190 Reduced 2.12%
54,882 $93,000
Q2 2024

Aug 14, 2024

BUY
$1.36 - $3.65 $1,482 - $3,978
1,090 Added 1.98%
56,072 $76,000
Q1 2024

May 09, 2024

BUY
$3.52 - $9.59 $98 - $268
28 Added 0.05%
54,982 $206,000
Q4 2023

Mar 05, 2024

BUY
$5.97 - $10.36 $429 - $745
72 Added 0.13%
54,954 $539,000
Q2 2023

Aug 08, 2023

SELL
$9.97 - $14.05 $1,994 - $2,810
-200 Reduced 0.36%
54,882 $729,000
Q1 2023

May 01, 2023

BUY
$7.94 - $12.02 $1,588 - $2,404
200 Added 0.36%
55,082 $638,000
Q1 2022

May 05, 2022

SELL
$8.43 - $20.9 $84 - $209
-10 Reduced 0.02%
54,882 $499,000
Q4 2021

Feb 02, 2022

BUY
$19.26 - $30.08 $116,388 - $181,773
6,043 Added 12.37%
54,892 $1.12 Million
Q3 2021

Oct 26, 2021

BUY
$24.86 - $35.02 $334,043 - $470,563
13,437 Added 37.94%
48,849 $1.25 Million
Q2 2021

Jul 27, 2021

SELL
$22.3 - $36.02 $518,341 - $837,248
-23,244 Reduced 39.63%
35,412 $1.24 Million
Q1 2021

Apr 27, 2021

BUY
$26.38 - $51.15 $33,819 - $65,574
1,282 Added 2.23%
58,656 $1.95 Million
Q4 2020

Jan 29, 2021

SELL
$10.5 - $28.5 $222,358 - $603,544
-21,177 Reduced 26.96%
57,374 $1.49 Million
Q3 2020

Nov 10, 2020

BUY
$3.61 - $9.87 $283,569 - $775,298
78,551 New
78,551 $775,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $443M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.